Shailaja Chikoti, MBBS

Shailaja Chikoti practices at MidState Medical Center in Meriden, Connecticut, part of Hartford HealthCare.

Shailaja Chikoti's NPI, 1134351935, was assigned on August 13, 2009. Shailaja Chikoti holds Connecticut license 061140.

Shailaja Chikoti's primary practice is MidState Medical Center, at 435 Lewis Avenue, Meriden, CT 06450 in New Haven County. The practice phone is (203) 694-8200.

Shailaja Chikoti's primary practice is MidState Medical Center in Meriden, Connecticut, part of Hartford HealthCare. Shailaja Chikoti is also affiliated with The Hospital of Central Connecticut. The medical group on file is MidState Medical Center. Dmand AI also links Shailaja Chikoti to 1 more hospice and 1 medical group, each named with a free account. Shailaja Chikoti's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Shailaja Chikoti practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Shailaja Chikoti's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Shailaja Chikoti's licenses on file in 2 states: Connecticut and New York.

CMS data shows 1,080 Medicare services from Shailaja Chikoti across 6 procedure codes in 2024, for 269 Medicare patients. Medicare paid $79,605 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 269 Medicare patients who saw Shailaja Chikoti in 2024. The largest group is 85 and over, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shailaja Chikoti's median patient age at 70, with 52% women.

In 2024, Shailaja Chikoti wrote 648 Medicare Part D claims for 279 patients. 85% of them were for generic drugs. CMS names the drug for 333 of them, across 12 drugs with 11 or more claims each, at $16,920 in total drug cost. In 2023, CMS named 185 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Shailaja Chikoti for performance year 2024, reported as part of a group. Shailaja Chikoti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Shailaja Chikoti in 2013. Shailaja Chikoti's most frequent co-author is Nischala Ammannagari, MD.

CMS Open Payments shows 4 general payments to Shailaja Chikoti from 2 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $50.